Type of β-blocker use among patients with versus without diabetes after myocardial infarction.
Arnold SV, Spertus JA, Lipska KJ, Lanfear DE, Tang F, Grodzinsky A, McGuire DK, Gore MO, Goyal A, Maddox TM, Kosiborod M.
Arnold SV, et al. Among authors: tang f.
Am Heart J. 2014 Sep;168(3):273-279.e1. doi: 10.1016/j.ahj.2014.04.018. Epub 2014 Jun 9.
Am Heart J. 2014.
PMID: 25173537
Free PMC article.